Industry News


Industry News
Global Trends
Events Calendar
Web Links

Web Gallery

Advertising  Info



Bayer's New Contour TS Blood Glucose Monitor Launched

It eliminates miscoding errors which could put people with diabetes at clinical risk

Bayer Diabetes Care, a division of Bayer HealthCare LLC and a member of the Bayer Group, recently introduced the new Contour TS blood glucose monitoring system in Mumbai. Bayer's Contour TS offers people with diabetes an accurate meter option with innovative ‘no coding’ technology, which provides reliable blood glucose test results and eliminates miscoding errors that could put people with diabetes at clinical risk.

Speaking to Express Healthcare, Gaetan de Kerros, Vice President, Region Asia, Diabetes Care, Singapore, said, "India is the first country where Contour TS is being launched, as right now it is the diabetes capital of the world. After Mumbai, we will be launching our product in Chennai, Kolkata and then Delhi."

Unlike most meters that need to be manually coded to ensure accurate results, Bayer's new Contour TS blood glucose meter automatically sets to the correct code any time a Bayer test strip is inserted. Manual coding may lead to miscoding. In fact, a recent study found that approximately 16 per cent-or one out of six persons failed to properly manually code their blood glucose meters to the lot of test strips being used.

"Miscoding may affect the success of self-monitoring of blood glucose in accurately measuring actual blood glucose values. No coding technology eliminates the risks associated with miscoding and improves the accuracy of blood glucose measurements. It increases confidence in blood glucose measurements, thereby reducing the risk of insulin dose errors that can sometimes lead to dangerous consequences," said Dr Pradeep Talwalkar, Professor of Diabetology, SL Raheja Hospital, Mumbai.

Some miscoded meters can generate results that may be inaccurate by over 40 per cent. Relying on a miscoded blood glucose meter could seriously impact therapeutic decisions for people who adjust their food intake, oral medication or insulin dosing based upon blood glucose readings.

A study published in the Journal of Diabetes Science and Technology in March 2007 showed that some miscoded meters could lead to under-dosing or overdosing insulin by two units 50 per cent of the time.

Insulin overdose may cause dangerously low blood sugar (hypoglycemia) leading to behavioral changes, confusion, loss of consciousness and, if untreated, seizure, coma and even death. Chronic underdosing of insulin may contribute to the long-term health problems associated with high blood sugar including kidney disease, nerve disease, eye problems, and heart disease.

“With Bayer's new Contour TS meters, people with diabetes can now obtain accurate blood glucose test results in just eight seconds. It also offers a small (0.6 µL) blood sample size and multiple-site (fingertip, palm or forearm) testing options,” added Dr Talwalkar.

(Ref: The Express Healthcare October 2007)

Roche Launches Insulin Pump

It is safe, simple, convenient, and optimises blood glucose levels

Roche Diagnostics Ltd recently introduced Accu-Chek Spirit, the new insulin pump in the market. Accu-Chek Spirit is launched for the first time in India and is available across six metros namely, Chennai, Bangalore, Mumbai, Delhi, Kolkata and Hyderabad.

The benefits of using Accu-Chek Spirit is that it is safe, easy, simple, convenient, and flexible, optimises blood glucose levels and helps significantly reduce long-term complications and the need of multiple daily injections is avoided, thus making the life of a diabetic independent and flexible. It also gives flexibility to choose what to eat, when to eat and how much to eat.

Additionally, sleeping patterns like going to bed early and sleeping late are as flexible as with non-diabetics, shift work, pregnancy or invitations for dinners are typical metabolic challenges that can be easily managed with an insulin pump and pumps are being used successfully by children, adolescents and pregnant or breast-feeding women.

Accu-Chek Spirit is the first insulin pump with three different operating menus. This innovative function provides the option to programme the insulin pump according to the people's level of experience and individual requirements.

The standard menu for beginners is easy to handle and provides the basic features of the pump. The advanced menu for experienced users allows the use of all the features Accu-Chek Spirit offers. The custom menu for individual needs enables the people with diabetes to choose menu functions according to preference.

According to Sanjay Gupta, Head, Roche Diagnostics Diabetes Care-India, "The launch of Accu-Chek Spirit has taken a step towards completing the circle between diabetes monitoring, insulin therapy and advice for people with diabetes to achieve better self management. The product is designed to make the life of diabetics the way they prefer."

(Ref: The Express Healthcare October 2007).


Other News

World's 1st 3D ICU Ventilator Launched
Mobile To Revolutionize Healthcare In Korea
Jubilant Organosys Bags Golden Peacock Global Award 2007
'Destiny'- a New Digital Aid For Indian Market By Starkey
HSBC PE (Asia) Fund, ePlanet To Invest US$ 11 Mn In Trivitron
Fresenius Group Net Profit Up By 28%
GE, Eli Lilly To Collaborate In Vitro Diagnostics For Cancer Treatment
Metropolis To Start Operations In US, Thailand With Investment In JV, Acquisition
Transasia Bio-Medicals Signs An Agreement With Grifols
GE Healthcare's Dexa Scan To Speed Up Bone Mineral Density Testing In Rural Areas
Alcon India Launches AcrySof® Restor® Lens
GE Healthcare To Augment Engg. Head Count By 10%
Indian Pharma Machinery Makers Go For Overseas Tie-Ups For Growth





Back | Back To Top | Previous | Next